Corticosteroid therapy for cardiac sarcoidosis a systematic review

Mild nasopharyngeal irritation following the use of beclomethasone aqueous nasal spray has been reported in up to 24% of patients treated, including occasional sneezing attacks (about 4%) occurring immediately following use of the spray. In patients experiencing these symptoms, none had to discontinue treatment. The incidence of transient irritation and sneezing was approximately the same in the group of patients who received placebo in these studies, implying that these complaints may be related to vehicle components of the formulation.

Systemic corticosteroids play an integral role in the management of many inflammatory and immunologic conditions, but these agents are also associated with serious risks. Osteoporosis, adrenal suppression, hyperglycemia, dyslipidemia, cardiovascular disease, Cushing's syndrome, psychiatric disturbances and immunosuppression are among the more serious side effects noted with systemic corticosteroid therapy , particularly when used at high doses for prolonged periods. This comprehensive article reviews these adverse events and provides practical recommendations for their prevention and management based on both current literature and the clinical experience of the authors.

Corticosteroid therapy for cardiac sarcoidosis a systematic review

corticosteroid therapy for cardiac sarcoidosis a systematic review

Media:

corticosteroid therapy for cardiac sarcoidosis a systematic reviewcorticosteroid therapy for cardiac sarcoidosis a systematic reviewcorticosteroid therapy for cardiac sarcoidosis a systematic reviewcorticosteroid therapy for cardiac sarcoidosis a systematic reviewcorticosteroid therapy for cardiac sarcoidosis a systematic review

http://buy-steroids.org